Ensoma, an in vivo cellular engineering company with a mission to advance the future of medicine through one-time therapies, today announced U.K. Medicines and Healthcare Products Regulatory Agency ...
A year of new treatments, new technologies, new ways to stay safe during disasters and new insights on the mysteries of the ...
Daniel Ives You can reverse the age of cells all the way down to zero in just a few weeks. So you can actually take a ...
Barclays 23rd Annual Global Technology Conference December 11, 2025 12:50 PM ESTCompany ParticipantsDaniel Lentz - Chief ...
Investigations suggest V2P may be efficiently applied for the automated identification of causal variants in simulated and actual patient sequencing data across phenotypes.
NEET UG 2026 is expected to witness intense competition, making NCERT-based preparation more crucial than ever for aspirants aiming for top medical colleges. Since the Biology section carries 90 ...
As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...
Mucommune, a Morrisville-based biotechnology company with roots at the University of North Carolina at Chapel Hill, has been ...
A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...
Global convertible bonds returned 9.1% in Q3 and 18.5% YTD amid 'Goldilocks' conditions. Read the full report to discover key ...
Sportschosun on MSN
Microplastics in Rheumatoid Arthritis synovial fluid...Determining the Arthritis-Deteriorating Proce...
Through a joint study with Professor Yoo Seung-ah of the Medical Life Science Class at Catholic University of Korea, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results